NeuroMetrix surges as FDA authorizes medical device

NeuroMetrix

19/05/2022 17:50

** Medical device maker's shares  NURO.O  up 33% at $4.16 in
afternoon trade - on track for biggest pct jump in over eight
months
    ** Says FDA authorizes to market co's Quell neuromodulation
device to help reduce symptoms of fibromyalgia, a condition that
causes widespread pain, sleep problems, among others
 urn:newsml:reuters.com:*:nGNX5FRvnB
    ** CEO Shai Gozani says co expects launch in Q4, with
initial prescriptions processed by an online pharmacy partner
before year-end
    ** Despite session's gain, stock down 17% YTD

 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))